IBXG logo

iBX Group, Inc. (IBXG) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cotizando a $, iBX Group, Inc. (IBXG) es una empresa del sector Healthcare valorada en 0. Calificado con 45/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 16 mar 2026
Puntuación de IA de 45/100

iBX Group, Inc. (IBXG) Resumen de Asistencia Médica y Tuberías

CEOYoshiko Tomori Shale
Empleados47
Sede CentralDeerfield Beach, US
Año de la oferta pública inicial (OPI)2002

iBX Group, Inc. provides administrative and technology solutions to the healthcare sector, operating through HTMT and PTR segments. Its offerings include practice management, billing services, and clinic operations. Facing a competitive landscape and negative gross margins, IBXG aims to serve healthcare providers with comprehensive support services.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 16 mar 2026

Tesis de Inversión

iBX Group, Inc. operates in the healthcare services sector, providing administrative and technological solutions. The company's two segments, HTMT and PTR, target different aspects of healthcare operations. However, with a negative gross margin of -164.0% and negative free cash flow, the company faces significant financial challenges. The high beta of 200.89 suggests extreme volatility relative to the market. Growth catalysts would likely depend on successful expansion of service offerings or improved operational efficiency. Investors should carefully consider the financial risks and competitive pressures before investing, given the OTC market listing and associated transparency concerns. The absence of a dividend further reduces its appeal for income-seeking investors.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Operates in two segments: Healthcare Transaction Management and Technology (HTMT) and Physical Therapy and Rehabilitation (PTR).
  • Provides administrative services, network support, and technology development to the healthcare industry.
  • Offers physician practice management, billing and collections, and staffing solutions through its HTMT segment.
  • Operates multidisciplinary clinics offering physical therapy, occupational medicine, and pain management through its PTR segment.
  • Based in Deerfield Beach, Florida, serving clients primarily in the United States.

Competidores y Pares

Fortalezas

  • Comprehensive service offerings through HTMT and PTR segments.
  • Established relationships with healthcare providers.
  • Integrated approach to administrative and clinical services.
  • Experienced management team.

Debilidades

  • Negative gross margin of -164.0%.
  • Negative free cash flow.
  • High beta indicating significant volatility.
  • Limited financial resources.

Catalizadores

  • Upcoming: Potential strategic partnerships with healthcare providers to expand service offerings.
  • Ongoing: Expansion of telehealth services to reach a broader patient base.
  • Ongoing: Enhancement of revenue cycle management services to improve financial performance.

Riesgos

  • Potential: Intense competition in the healthcare services market.
  • Potential: Regulatory changes impacting healthcare operations.
  • Ongoing: Negative gross margin and free cash flow.
  • Ongoing: High beta indicating significant volatility.
  • Potential: Limited liquidity due to OTC market listing.

Oportunidades de crecimiento

  • Expansion of Telehealth Services: The increasing adoption of telehealth presents a significant growth opportunity for iBX Group, Inc. By integrating telehealth solutions into its HTMT segment, the company can offer remote patient monitoring, virtual consultations, and online therapy services. The telehealth market is projected to reach $55.6 billion by 2027, growing at a CAGR of 23.5%. This expansion would allow iBX Group to reach a broader patient base and generate additional revenue streams, enhancing its competitive position in the healthcare sector. Timeline: Within the next 2-3 years.
  • Strategic Partnerships with Healthcare Providers: Forming strategic alliances with hospitals, clinics, and physician groups can drive growth for iBX Group, Inc. These partnerships can facilitate the integration of iBX's administrative and technology solutions into healthcare providers' existing workflows, improving efficiency and reducing operational costs. By leveraging these partnerships, iBX Group can secure long-term contracts and expand its market reach. This collaborative approach can lead to a more integrated and patient-centric healthcare delivery system. Timeline: Ongoing.
  • Enhancement of Revenue Cycle Management Services: Improving its revenue cycle management (RCM) services within the HTMT segment can significantly boost iBX Group, Inc.'s financial performance. By leveraging advanced analytics and automation, the company can optimize billing processes, reduce claim denials, and accelerate revenue collection. The global RCM market is expected to reach $107.4 billion by 2028, growing at a CAGR of 12.5%. Enhancing RCM capabilities would enable iBX Group to capture a larger share of this market and improve its financial stability. Timeline: Within the next 1-2 years.
  • Geographic Expansion of PTR Services: Expanding the geographic footprint of its Physical Therapy and Rehabilitation (PTR) services can drive growth for iBX Group, Inc. By opening new clinics in underserved areas or acquiring existing practices, the company can reach a wider patient population and increase its revenue base. The demand for physical therapy and rehabilitation services is growing due to the aging population and increasing prevalence of chronic conditions. This expansion would allow iBX Group to capitalize on this growing demand and strengthen its market position. Timeline: Over the next 3-5 years.
  • Development of Proprietary Healthcare Technology: Investing in the development of proprietary healthcare technology solutions can create a significant competitive advantage for iBX Group, Inc. By developing innovative software applications and platforms that address specific needs within the healthcare industry, the company can differentiate itself from competitors and attract new clients. This could include solutions for electronic health records (EHR), patient engagement, or data analytics. Proprietary technology can also generate recurring revenue streams through licensing and subscription models. Timeline: Ongoing.

Oportunidades

  • Expansion of telehealth services.
  • Strategic partnerships with healthcare providers.
  • Enhancement of revenue cycle management services.
  • Geographic expansion of PTR services.

Amenazas

  • Intense competition in the healthcare services market.
  • Regulatory changes impacting healthcare operations.
  • Economic downturn affecting healthcare spending.
  • Technological advancements rendering existing services obsolete.

Ventajas competitivas

  • Established presence in the healthcare administrative services market.
  • Integrated service offerings through HTMT and PTR segments.
  • Long-term relationships with healthcare providers.
  • Proprietary technology solutions for healthcare management.

Acerca de IBXG

Founded in 1997 as Vidkid Distribution, Inc., iBX Group, Inc. has evolved into a provider of administrative services, network support, and technology solutions primarily for the healthcare sector in the United States. The company operates through two main segments: Healthcare Transaction Management and Technology (HTMT) and Physical Therapy and Rehabilitation (PTR). The HTMT segment offers a suite of services including physician practice management, billing and collections, network services, transcription services, staffing solutions, and software application development. This segment aims to streamline administrative processes and enhance operational efficiency for healthcare providers. The PTR segment operates multidisciplinary clinics that provide physical therapy, occupational medicine, pain management, chiropractic care, and wellness services. These clinics offer integrated care to patients seeking rehabilitation and pain relief. Headquartered in Deerfield Beach, Florida, iBX Group, Inc. focuses on delivering comprehensive support services to healthcare clients.

Qué hacen

  • Provides administrative services to healthcare clients.
  • Offers network support and maintenance.
  • Delivers technology development services.
  • Manages physician practices.
  • Handles billing and collections.
  • Provides transcription services.
  • Offers staffing solutions.
  • Develops software applications.

Modelo de Negocio

  • Generates revenue through Healthcare Transaction Management and Technology (HTMT) services.
  • Generates revenue through Physical Therapy and Rehabilitation (PTR) services.
  • Offers administrative services on a contract basis.
  • Provides technology solutions through licensing and service agreements.

Contexto de la Industria

iBX Group, Inc. operates within the healthcare services industry, which is characterized by increasing demand for administrative and technological solutions to manage complex healthcare operations. The industry is highly competitive, with companies like ACBM, AMBS, AXMP, DECN, and HDVY offering similar services. Market trends include the growing adoption of telehealth, increasing focus on value-based care, and the need for efficient revenue cycle management. iBX Group's success depends on its ability to differentiate its services and effectively compete in this dynamic environment.

Clientes Clave

  • Physician practices
  • Hospitals and clinics
  • Healthcare networks
  • Rehabilitation centers
  • Individual patients seeking physical therapy
Confianza de la IA: 69% Actualizado: 16 mar 2026

Finanzas

Gráfico e información

Precio de la acción de iBX Group, Inc. (IBXG): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para IBXG.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para IBXG.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para IBXG.

MoonshotScore

45/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de IBXG en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Yoshiko Tomori Shale

CEO

Yoshiko Tomori Shale is the CEO of iBX Group, Inc., managing a team of 47 employees. Her background includes extensive experience in healthcare administration and management. Prior to joining iBX Group, she held leadership positions in various healthcare organizations, focusing on operational efficiency and strategic growth. Her expertise spans across healthcare technology, revenue cycle management, and clinical operations. She is known for her ability to drive innovation and improve patient outcomes.

Historial: Under Yoshiko Tomori Shale's leadership, iBX Group, Inc. has focused on expanding its service offerings and strengthening its relationships with healthcare providers. She has overseen the integration of new technologies into the company's HTMT segment and the expansion of its PTR services. Key milestones include the development of proprietary healthcare technology solutions and the implementation of strategic partnerships to drive growth. However, the company continues to face financial challenges, including negative gross margins and free cash flow.

Información del mercado OTC de IBXG

The OTC Other tier represents the lowest tier of the OTC market, indicating that iBX Group, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and transparency compared to those listed on major exchanges like NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the potential for less regulatory oversight and information availability. This tier is generally associated with speculative investments.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Liquidity for iBX Group, Inc. on the OTC market is likely limited, given its listing on the OTC Other tier. This typically translates to low trading volume and potentially wide bid-ask spreads, making it challenging to buy or sell shares quickly without significantly impacting the price. The limited liquidity can increase the risk of price volatility and make it difficult for investors to exit their positions, especially in large quantities.
Factores de riesgo OTC:
  • Limited regulatory oversight and financial reporting requirements.
  • Low trading volume and liquidity.
  • Potential for price manipulation and volatility.
  • Higher risk of fraud or misrepresentation.
  • Limited access to company information and management.
Lista de verificación de diligencia debida:
  • Verify the company's legal status and registration.
  • Review available financial statements and disclosures.
  • Assess the company's business model and competitive landscape.
  • Evaluate the management team's experience and track record.
  • Check for any regulatory actions or legal disputes.
  • Monitor trading volume and price volatility.
  • Consult with a financial advisor or legal professional.
Señales de legitimidad:
  • Company has been in operation since 1997.
  • Operates in the healthcare sector, providing essential services.
  • Has a CEO with experience in healthcare administration.
  • Maintains a physical headquarters in Deerfield Beach, Florida.

IBXG Preguntas Frecuentes sobre Acciones de Healthcare

¿Cuáles son los factores clave para evaluar IBXG?

iBX Group, Inc. (IBXG) actualmente tiene una puntuación IA de 45/100, indicando puntuación baja. Fortaleza clave: Comprehensive service offerings through HTMT and PTR segments.. Riesgo principal a monitorear: Potential: Intense competition in the healthcare services market.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de IBXG?

IBXG actualmente puntúa 45/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de IBXG?

Los precios de IBXG se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre IBXG?

La cobertura de analistas para IBXG incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en IBXG?

Las categorías de riesgo para IBXG incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Intense competition in the healthcare services market.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de IBXG?

La relación P/E para IBXG compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está IBXG sobrevalorada o infravalorada?

Determinar si iBX Group, Inc. (IBXG) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de IBXG?

iBX Group, Inc. (IBXG) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Financial data is limited and may not be fully up-to-date.
  • OTC market investments carry higher risks than exchange-listed stocks.
  • AI analysis is pending and may provide further insights.
Fuentes de datos

Popular Stocks